Equity-Based Compensation (Tables)

3 Months Ended

Mar. 31, 2022

Share-based Payment Arrangement [Abstract]

Schedule of Stock Options Activity

The following table summarizes our stock options activity:

	Number of Options		Weighted- average exercise price per share		Weighted- average remaining contractual term (in years)		Aggregate intrinsic value
Outstanding, December 31, 2021		3,071,613	$	13.12		8.5	$	—
Granted		450,078	$	8.42
Outstanding March 31, 2022		3,521,691	$	12.52		8.5	$	—
Exercisable at March 31, 2022		346,575	$	13.93		7.1	$	—

Schedule of Equity-based Compensation Expense

Equity-based compensation expense recorded as research and development and general and administrative expenses is as follows (in thousands):

	Three Months Ended March 31,
	2022		2021
Research and development	$	685	$	1
General and administrative		935		3
Total equity-based compensation	$	1,620	$	4